Levine Media Group

Deniz Kent, co-founder and CEO of Prolific Machines, discusses the company’s photomolecular platform technology, the benefits it provides over traditional biomanufacturing methods, and how it could be used to cultivate not just meat but a steak. https://lnkd.in/gzzW9XiE

Bio Usawa Inc., which is working to bring affordable biosimilars to Africa through innovation and partnerships that are creating biomanufacturing capacity, continues to expand its team. The company appointed the Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory Strategy. https://lnkd.in/eX7QXXpt

Neil Kumar, co-founder and CEO of BridgeBio, discusses the approval of its ATTR-CM therapy Attruby, the company’s late-stage pipeline, and what he’s learned about its business model in the process. Global Genes #RARECast https://lnkd.in/dPRVYtWK

Michael Nally, CEO of Generate:Biomedicines, sits down with Amar Drawid, Ph.D. to discuss the innovative use of generative AI in drug discovery, how the company’s platform integrates machine learning with biological engineering to create new therapeutic proteins, and the potential of generative AI to create more effective therapies for cancer and infectious diseases. https://lnkd.in/gt6dbxkT

Sungwon Lim, CEO of ImpriMed, Inc., discusses the company's AI platform to match cancer patients to the best available therapy for them, its decision to roll out the service first to the veterinary market, and what it is doing to bring its service to humans. https://lnkd.in/gFQsa63R

Tomi Pastinen, director of the Center for Pediatric Genomic Medicine at Children's Mercy Kansas City, discusses the success of the Genomic Answers for Kids program to date, reimbursement challenges, and the future of the technology. Global Genes https://lnkd.in/gNfuCbjD

Eswar I., co-founder and CEO of Aikium Inc., discusses the novel class of SeqR proteins the company is developing, how they can bind to targets that traditional medicines can’t, and the potential to transform drug development by expanding the world of druggable targets with the use of AI. https://lnkd.in/gjxrkrPc

Here's what you may have missed in November from The Bio Report, RARECast, Life Sciences D'n'A, and MitoCast podcasts. https://lnkd.in/gsC4Zxf9

Friedreich's ataxia patient advocate Anthony Monaco discusses coming to terms with his diagnosis, how he was forced to abandon some dreams, and how he was able to find new ones to pursue. Global Genes https://lnkd.in/gqsF6rQd

Kannan Raman of Amazon Web Services (AWS) sits down with Amar Drawid, Ph.D. to discuss the role of AI in transforming life sciences and the importance of data strategy being tied to business outcomes. They explore the challenges of data strategy, the importance of cultural shifts within organizations, and the monetization of data as a product. https://lnkd.in/g4qua-Rt